BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
June 03, 2026 21:55 ET | Source: BrightSpring Health Services, Inc. LOUISVILLE,…
POP Biotechnologies Secures Up to $9.7 Million in CEPI Funding
Funding to Propel POP BIO SNAP™ Nanoparticle Vaccine Platform into Phase 1…
ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir
CHAPEL HILL, N.C., June 03, 2026 (GLOBE NEWSWIRE) -- ACTG, a global…
Nord Security reaches 100% renewable energy in offices and colocation services, doubles nonprofit support
LONDON, June 03, 2026 (GLOBE NEWSWIRE) -- Nord Security, the company behind NordVPN,…
Nord Security and Acronis partner to unify network and endpoint security management for MSPs
NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Nord Security, a global…
Diginex Provides Update on Proposed Resulticks Acquisition
LONDON, June 03, 2026 (GLOBE NEWSWIRE) -- Diginex Limited (Nasdaq: DGNX), a…
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogrens Disease at EULAR 2026
ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and…
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
Favorable safety and tolerability profile, with rapid onset of clinical activity and…
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
Nipocalimab – the first neonatal Fc receptor (FcRn) blocker to be studied…
Fluent Inc. Subsidiary Trevant Launches as Creator Marketing Agency Built on Performance Discipline
Trevant pairs creator-native expertise with the measurement and scale infrastructure AdParlor spent…
